03:42 AM EDT, 04/23/2026 (MT Newswires) -- Eric Venker, President & Immunovant Chief Executive Officer, on April 20, 2026, sold 200,000 shares in Roivant Sciences ( ROIV ) for $5,918,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1635088/000163508826000044/xslF345X05/wk-form4_1776896865.xml